Aurora Cannabis revenues rise in Q2, led by strength in medical cannabis sales
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on brandonsun.com
- Read the Brandon Sun E-Edition, our digital replica newspaper
*Your next Free Press subscription payment will increase by $1.00 and you will be charged $20.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 09/11/2023 (1074 days ago), so information in it may no longer be current.
EDMONTON – Aurora Cannabis Inc. says it earned $256,000 in the second quarter, up from a loss a year earlier of $45.5 million.
The Edmonton-based cannabis company says net revenue for the quarter was $63.4 million, up from $48.6 million during the same quarter a year earlier.
The company attributed the increase to growth in its global medical cannabis business and quarterly revenue in its plant propagation business.
CEO Miguel Martin says it was the company’s strongest fiscal year to date.
He says Aurora is experiencing the benefits of diversification across its cannabis and non-cannabis platforms.
The company’s net revenue from medical cannabis rose 42 per cent from a year earlier, while revenues from consumer cannabis were slightly lower.
This report by The Canadian Press was first published Nov. 9, 2023.
Companies in this story: (TSX:ACB)